Perspectives for Developing New Tuberculosis Vaccines Derived from the Pathogenesis of Tuberculosis: I. Basic Principles, II. Preclinical Testing, and III. Clinical Testing
Part I. Basic Principles. TB vaccines cannot prevent establishment of the infection. They can only prevent an early pulmonary tubercle from developing into clinical disease. A more effective new vaccine should optimize both cell-mediated immunity (CMI) and delayed-type hypersensitivity (DTH) better...
Main Authors: | Bappaditya Dey, Arthur M. Dannenberg |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2013-01-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | http://www.mdpi.com/2076-393X/1/1/58 |
Similar Items
-
Tuberculosis the great mimicker: Five unusual cases
by: Shohael Mahmud Arafat, et al.
Published: (2024-11-01) -
Universal drug-susceptibility testing of first-line drugs to preserve their efficacy: An essential strategy to defeat tuberculosis
by: Madhur Dev Bhattarai
Published: (2023-12-01) -
Application Values of T-SPOT.TB in Clinical Rapid Diagnosis of Tuberculosis
by: Feng ZHU, et al.
Published: (2017-12-01) -
Survey of spinal tuberculosis in Basrah
by: Rabee A. Chaloob, et al.
Published: (2024-09-01) -
Utility of stool Xpert MTB/Rif assay in the diagnosis of pulmonary and abdominal tuberculosis in children - A study from Western India
by: Ira Shah, et al.
Published: (2025-03-01)